Frank Karbe
Directeur/Membre du Conseil chez PHATHOM PHARMACEUTICALS, INC.
Fortune : 86 639 $ au 30/04/2024
Provenance du réseau au premier degré de Frank Karbe
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
Goldman Sachs & Co. LLC
 Goldman Sachs & Co. LLC Financial ConglomeratesFinance Goldman Sachs & Co. LLC (GS&Co.) is a securities brokerage firm headquartered in New York City. Founded in 1927, the firm is a subsidiary of The Goldman Sachs Group, Inc. (NYSE: GS). GS&Co. provides services to help hedge funds manage risk, monitor portfolios, maintain liquidity and build their businesses. They offer clients access to global equity and derivatives markets, as well as foreign exchange, commodities, European Lefts, rates and credit across the Americas, Europe and Asia. The firm proactively monitors capital markets, searching for pockets of liquidity and news that may require changes to those strategies. Integration with the Goldman Sachs network gives clients access to the firm's sectored block trades and their insights into price discovery. Their electronic trading program provides clients with tools to manage their trades from pre-trade analytics to post-trade analysis.
753
| Subsidiary | Financial Conglomerates | 753 |
| Public Company | Pharmaceuticals: Major | 36 | |
| Public Company | Pharmaceuticals: Major | 34 | |
| Subsidiary | Biotechnology | 22 | |
| Public Company | Pharmaceuticals: Major | 15 | |
| Public Company | Medical Specialties | 12 | |
| Extinct | Pharmaceuticals: Major | 10 | |
Navigen, Inc.
 Navigen, Inc. Pharmaceuticals: MajorHealth Technology Navigen, Inc. operates as a drug discovery and development company. The company was founded by Hunter Jackson and is headquartered in Salt Lake City, UT.
9
| Holding Company | Pharmaceuticals: Major | 9 |
Myovant Sciences, Inc.
 Myovant Sciences, Inc. Medical SpecialtiesHealth Technology Myovant Sciences, Inc. offers therapeutics for women's health and prostate cancer. The company is headquartered in New York, NY.
6
| Subsidiary | Medical Specialties | 6 |
Kolltan Pharmaceuticals, Inc.
 Kolltan Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Kolltan Pharmaceuticals, Inc. engaged in the development of monoclonal antibody drugs. It focused on the discovery and development of novel antibody-based drugs targeting receptor tyrosine kinases (RTKs) for the treatment of cancer and other diseases. The company was founded by Arthur G. Altschul, Jr. and Joseph P. Schlessinger on November 16, 2007 and was headquartered in New Haven, CT.
2
| Extinct | Pharmaceuticals: Major | 2 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Frank Karbe via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
Better Therapeutics LLC
 Better Therapeutics LLC Medical SpecialtiesHealth Technology Part of Better Therapeutics, Inc., Better Therapeutics LLC is a company that focuses on clinical development and creating habits that heal to reduce the need for other treatments. The company is based in San Francisco, CA. The company is pioneers in the field of prescription digital therapeutics for treating a range of cardiometabolic diseases. The company was founded by David P. Perry and Kevin J. Appelbaum. Kevin J. Appelbaum has been the CEO of the company since 2015. Better Therapeutics was acquired by Mountain Crest Acquisition Corp. II on October 28, 2021 for $164.55 million. | Medical Specialties | Founder Director/Board Member Director/Board Member Founder Director/Board Member Director/Board Member Director/Board Member | |
Roivant Sciences, Inc.
 Roivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Roivant Sciences, Inc. operates as a pharmaceutical firm. It develops and markets drugs. The firm specializes in uterine fibroids, endometriosis, prostate cancer, diabetes, and pulmonary arterial hypertension. The company was founded by Vivek Ramaswamy in 2014 and is headquartered in New York, NY. | Pharmaceuticals: Major | Corporate Officer/Principal Director/Board Member Chief Executive Officer Director/Board Member Corporate Officer/Principal Director/Board Member | |
| MERCK & CO., INC. | Pharmaceuticals: Major | Comptroller/Controller/Auditor Director/Board Member Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| University of Pennsylvania | College/University | Undergraduate Degree Corporate Officer/Principal Undergraduate Degree Undergraduate Degree Doctorate Degree | |
Arbutus Biopharma, Inc.
 Arbutus Biopharma, Inc. BiotechnologyHealth Technology Arbutus Biopharma, Inc. engages in the research and development of pharmaceutical products for Hepatitis B. Its operation includes covalently closed circular DNA, Capsid Assembly, Cyclophilins, and Surface Antigen. The company was founded by Patrick T. Higgins, Michael J. Sofia, Michael J. McElhaugh, and Bryce A. Roberts in May 2012 and is headquartered in Doylestown, PA. | Biotechnology | Director/Board Member Director/Board Member Director/Board Member Founder Chief Executive Officer | |
| Stanford University | College/University | Doctorate Degree Undergraduate Degree Corporate Officer/Principal Masters Business Admin Undergraduate Degree | |
| The University of Chicago | College/University | Graduate Degree Director/Board Member Doctorate Degree Undergraduate Degree Doctorate Degree | |
| Georgetown University | College/University | Undergraduate Degree Doctorate Degree Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
| NPS PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Executive Officer Founder General Counsel Public Communications Contact | |
| THE GOLDMAN SACHS GROUP, INC. | Investment Banks/Brokers | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Chief Executive Officer | |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Chief Tech/Sci/R&D Officer Chief Operating Officer Corporate Officer/Principal Corporate Officer/Principal | |
| ABBOTT LABORATORIES | Medical Specialties | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| Harvard Medical School | College/University | Doctorate Degree Corporate Officer/Principal Doctorate Degree Doctorate Degree | |
| Yale University | College/University | Doctorate Degree Doctorate Degree Undergraduate Degree Undergraduate Degree | |
| The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin Masters Business Admin Masters Business Admin Masters Business Admin | |
| GILEAD SCIENCES, INC. | Biotechnology | Compliance Officer Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
Roivant Sciences GmbH
 Roivant Sciences GmbH Pharmaceuticals: MajorHealth Technology Roivant Sciences GmbH engages in the development and marketing of biopharmaceutical products. The company was founded by Vivek Ramaswamy in 2014 and is headquartered in Basel, Switzerland. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member Corporate Officer/Principal | |
| EIGER BIOPHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director of Finance/CFO Director of Finance/CFO Director/Board Member | |
MPEX Pharmaceuticals, Inc.
 MPEX Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services MPEX Pharmaceuticals, Inc. develops and manufactures therapies for antibiotic resistance with focus on gram-negative organisms. It offers Aeroquin (MP- 376), an aerosol formulation of levofloxacin for the treatment of pulmonary infections in patients with cystic fibrosis, as well as antibiotic programs to address antibiotic resistance in gram negative organisms. The company was founded in 2001 and is headquartered in San Diego, CA. | Miscellaneous Commercial Services | Director/Board Member Chief Executive Officer Founder | |
| DYNAVAX TECHNOLOGIES CORPORATION | Biotechnology | Director/Board Member Director/Board Member Director of Finance/CFO | |
| CELGENE | Biotechnology | Corporate Officer/Principal Human Resources Officer Corporate Officer/Principal | |
| University of California San Diego | College/University | Corporate Officer/Principal Undergraduate Degree Undergraduate Degree | |
| Harvard College | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
| Harvard Business School | College/University | Masters Business Admin Masters Business Admin Masters Business Admin | |
| ROIVANT SCIENCES LTD. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal Chief Executive Officer | |
| TAKEDA PHARMACEUTICAL COMPANY LIMITED | Pharmaceuticals: Major | Corporate Officer/Principal Chief Tech/Sci/R&D Officer General Counsel | |
| SIO GENE THERAPIES INC. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer President | |
| University of British Columbia | College/University | Corporate Officer/Principal Undergraduate Degree Undergraduate Degree | |
Pharmasset, Inc.
 Pharmasset, Inc. Pharmaceuticals: OtherHealth Technology Pharmasset, Inc. developed drugs to treat viral infections. It focued in the development of oral therapeutics for the treatment of hepatitis C virus (HCV) infection. The company was founded in 1998 and was headquartered in Princeton, NJ. | Pharmaceuticals: Other | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
Sumitovant Biopharma, Inc.
 Sumitovant Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Sumitovant Biopharma, Inc. provides biotechnology services. It offers oncology, gene therapy, rare, pulmonary, urological disease, digital innovation and novel platforms. The company is headquartered in New York, NY. | Pharmaceuticals: Major | Chief Executive Officer Corporate Officer/Principal Director/Board Member | |
| Princeton University | College/University | Undergraduate Degree Director/Board Member Undergraduate Degree | |
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
Duke University
 Duke University Other Consumer ServicesConsumer Services Duke University is an academic university that offers undergraduate, graduate and professional programs. It also has publications and research services. The university was founded in 1838 and is headquartered in Durham, NC. | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
| GE AEROSPACE | Industrial Machinery | Corporate Officer/Principal Director/Board Member | |
Association of American Physicians
 Association of American Physicians Miscellaneous Commercial ServicesCommercial Services The Association of American Physicians operates as an American association of physicians. The non-profit company is based in Tucson, AZ. The company was founded by Charles Lee. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
| University of Michigan | College/University | Undergraduate Degree Masters Business Admin | |
| University of Missouri | College/University | Undergraduate Degree Graduate Degree | |
| PFIZER, INC. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
Athyrium Capital Management LP
 Athyrium Capital Management LP Investment ManagersFinance Athyrium Capital Management LP (Athyrium) is an independent, SEC-registered investment advisor and hedge fund manager headquartered in New York City. The firm was founded by Jeffrey A. Ferrell in 2008 as Athyrium Capital Management LLC and converted from a Delaware limited liability company to a Delaware limited partnership in 2015. Athyrium provides advisory services on a discretionary basis to its clients, which may include specific tailored vehicles and pooled investment vehicles intended for sophisticated investors and institutional investors. | Investment Managers | Consultant / Advisor Portfolio Manager-Equities | |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Chairman Corporate Officer/Principal | |
| ASTRAZENECA PLC | Pharmaceuticals: Major | Founder Corporate Officer/Principal | |
| University of Oklahoma | College/University | Undergraduate Degree Masters Business Admin | |
QVT Financial LP
 QVT Financial LP Investment ManagersFinance QVT Financial LP is an independent, SEC-registered investment advisor and hedge fund manager headquartered in New York City. The firm was founded in 2003 by Daniel Gold. QVT Financial provides administrative and/or investment management services to private funds including US limited partnerships, non-US limited partnerships and non-US Corporation. | Investment Managers | Portfolio Manager-Equities Analyst-Equity | |
Goldman Sachs Asset Management LP
 Goldman Sachs Asset Management LP Investment ManagersFinance Goldman Sachs Asset Management LP (GSAMLP) is a SEC-registered investment advisor headquartered in New York City. The firm is a wholly owned subsidiary of GSAM Holdings LLC, and their ultimate parent is Goldman Sachs Group, Inc. (NYSE: GS). Founded in 1988, GSAMLP provides investment solutions to a range of individual and institutional investors worldwide. | Investment Managers | Analyst-Equity Chief Executive Officer | |
| Rutgers State University of New Jersey | College/University | Undergraduate Degree Masters Business Admin | |
| New York University School of Law | College/University | Graduate Degree Graduate Degree | |
| Cadence Pharmaceuticals , Inc. | Founder Corporate Officer/Principal | ||
Sumitomo Pharma America, Inc.
 Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Sumitomo Pharma America, Inc. operates as a biopharmaceutical company that develops pharmaceutical products. Its products include Aptiom (eslicarbazepine acetate) tablets, Latuda (lurasidone HCl) tablets, Lunesta (eszopiclone) tablets, Xopenex (levalbuterol HCl) Inhalation Solution, Xopenex HFA (levalbuterol tartrate) Inhalation Aerosol, Brovana (arformoterol tartrate) Inhalation Solution, Omnaris (ciclesonide) Nasal Spray, Alvesco (ciclesonide) Inhalation Aerosol, and Zetonna (ciclesonide) Nasal Aerosol. The company was founded in 2010 and is headquartered in Marlborough, MA. | Pharmaceuticals: Major | Chief Executive Officer Corporate Officer/Principal |
Statistiques
Internationale
| Etats-Unis | 44 |
| Royaume-Uni | 3 |
| Canada | 3 |
| Suisse | 2 |
| Japon | 2 |
Sectorielle
| Health Technology | 24 |
| Consumer Services | 19 |
| Finance | 5 |
| Commercial Services | 4 |
| Producer Manufacturing | 2 |
Opérationnelle
| Director/Board Member | 499 |
| Corporate Officer/Principal | 232 |
| Independent Dir/Board Member | 150 |
| Chairman | 89 |
| Undergraduate Degree | 85 |
Relations les plus connectées
| Insiders | |
|---|---|
| James Topper | 49 |
| Myrtle Potter | 41 |
| Elder Granger | 36 |
| Risa Lavizzo-Mourey | 33 |
| Ken Galbraith | 30 |
| Dan Kisner | 29 |
| Daniel Burgess | 28 |
| Richard Carmona | 26 |
| Stephen Sherwin | 26 |
| Lawton Fitt | 25 |
| David Socks | 24 |
| Wayne DeVeydt | 24 |
| Ronald Ian Lennox | 22 |
| Chris McFadden | 22 |
| Francis McCormick | 21 |
- Bourse
- Insiders
- Frank Karbe
- Connexions Sociétés
